oxymetholone has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abish, S; Ali, SS; Breakey, VR; Brossard, J; Cada, M; Català, A; Corriveau-Bourque, C; Cuvelier, GDE; Dror, Y; Fernandez, CV; Goodyear, L; Jardine, L; Klaassen, RJ; Lauhasurayotin, S; Lipton, JH; Michon, B; Pastore, YD; Rayar, M; Silva, M; Sinha, R; Steele, M; Sung, L; Zlateska, B | 1 |
| Alikaşifoglu, M; Altay, C; Kara, A; Ozbek, N; Schroeder-Kurth, TM; Tunçbilek, E | 1 |
2 other study(ies) available for oxymetholone and Disease Exacerbation
| Article | Year |
|---|---|
Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.
Topics: Adolescent; Adult; Androgens; Bone Marrow Failure Disorders; Canada; Cell Lineage; Child; Child, Preschool; Combined Modality Therapy; Danazol; Disease Progression; Drug Substitution; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Oxymetholone; Pancytopenia; Registries; Thrombocytopenia; Treatment Outcome; Virilism | 2020 |
Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience.
Topics: Abnormalities, Multiple; Adolescent; Adult; Anemia, Aplastic; Child; Child, Preschool; Consanguinity; Disease Progression; Epoxy Compounds; Fanconi Anemia; Female; Follow-Up Studies; Humans; Infant; Male; Oxymetholone; Pedigree; Turkey | 1997 |